JENBURKT PHARMA Q2 FY27 ; STANDALONE NET PROFIT FLAT AT ₹10 CR (YOY), UP 73% (QOQ)

REVENUE UP 6% AT ₹48 CR (YOY), UP 36% (QOQ) EBITDA DOWN 1% AT ₹13 CR (YOY), UP 116% (QOQ) MARGINS AT 26.9% VS 28.8% (YOY), 17.0% (QOQ)

JENBURKT PHARMACEUTICAL L